These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20197402)

  • 1. IFN-beta restricts tumor growth and sensitizes alveolar rhabdomyosarcoma to ionizing radiation.
    Sims TL; McGee M; Williams RF; Myers AL; Tracey L; Hamner JB; Ng C; Wu J; Gaber MW; McCarville B; Nathwani AC; Davidoff AM
    Mol Cancer Ther; 2010 Mar; 9(3):761-71. PubMed ID: 20197402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved intratumoral oxygenation through vascular normalization increases glioma sensitivity to ionizing radiation.
    McGee MC; Hamner JB; Williams RF; Rosati SF; Sims TL; Ng CY; Gaber MW; Calabrese C; Wu J; Nathwani AC; Duntsch C; Merchant TE; Davidoff AM
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1537-45. PubMed ID: 20338480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin potentiates rhabdomyosarcoma radiosensitivity by suppressing NF-κB activity.
    Orr WS; Denbo JW; Saab KR; Ng CY; Wu J; Li K; Garner JM; Morton CL; Du Z; Pfeffer LM; Davidoff AM
    PLoS One; 2013; 8(2):e51309. PubMed ID: 23408929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bevacizumab-induced tumor vessel remodeling in rhabdomyosarcoma xenografts increases the effectiveness of adjuvant ionizing radiation.
    Myers AL; Williams RF; Ng CY; Hartwich JE; Davidoff AM
    J Pediatr Surg; 2010 Jun; 45(6):1080-5. PubMed ID: 20620299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin-induced tumor vasculature remodeling in rhabdomyosarcoma xenografts increases the effectiveness of adjuvant ionizing radiation.
    Myers AL; Orr WS; Denbo JW; Ng CY; Zhou J; Spence Y; Wu J; Davidoff AM
    J Pediatr Surg; 2012 Jan; 47(1):183-9. PubMed ID: 22244414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metronomic small molecule inhibitor of Bcl-2 (TW-37) is antiangiogenic and potentiates the antitumor effect of ionizing radiation.
    Zeitlin BD; Spalding AC; Campos MS; Ashimori N; Dong Z; Wang S; Lawrence TS; Nör JE
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):879-87. PubMed ID: 20675079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype.
    Rossetti A; Petragnano F; Milazzo L; Vulcano F; Macioce G; Codenotti S; Cassandri M; Pomella S; Cicchetti F; Fasciani I; Antinozzi C; Di Luigi L; Festuccia C; De Felice F; Vergine M; Fanzani A; Rota R; Maggio R; Polimeni A; Tombolini V; Gravina GL; Marampon F
    Int J Radiat Biol; 2021; 97(7):943-957. PubMed ID: 33979259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
    Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
    Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal treatment scheduling of ionizing radiation and sunitinib improves the antitumor activity and allows dose reduction.
    Kleibeuker EA; Ten Hooven MA; Castricum KC; Honeywell R; Griffioen AW; Verheul HM; Slotman BJ; Thijssen VL
    Cancer Med; 2015 Jul; 4(7):1003-15. PubMed ID: 25828633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secreted Frizzled-Related Protein 3 (SFRP3) Is Required for Tumorigenesis of PAX3-FOXO1-Positive Alveolar Rhabdomyosarcoma.
    Kephart JJ; Tiller RG; Crose LE; Slemmons KK; Chen PH; Hinson AR; Bentley RC; Chi JT; Linardic CM
    Clin Cancer Res; 2015 Nov; 21(21):4868-80. PubMed ID: 26071485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor tyrosine kinase inhibitor AZD2171 and fractionated radiotherapy in mouse models of lung cancer.
    Cao C; Albert JM; Geng L; Ivy PS; Sandler A; Johnson DH; Lu B
    Cancer Res; 2006 Dec; 66(23):11409-15. PubMed ID: 17145887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase C-beta inhibitor enzastaurin (LY317615.HCI) enhances radiation control of murine breast cancer in an orthotopic model of bone metastasis.
    Dudek AZ; Zwolak P; Jasinski P; Terai K; Gallus NJ; Ericson ME; Farassati F
    Invest New Drugs; 2008 Feb; 26(1):13-24. PubMed ID: 17805485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of ionizing radiation response by histamine in vitro and in vivo in human breast cancer.
    Martinel Lamas DJ; Cortina JE; Ventura C; Sterle HA; Valli E; Balestrasse KB; Blanco H; Cremaschi GA; Rivera ES; Medina VA
    Cancer Biol Ther; 2015; 16(1):137-48. PubMed ID: 25482934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of interferon beta-induced radiosensitization in four out of five human glioblastoma cell lines.
    Schmidberger H; Rave-Fränk M; Lehmann J J; Weiss E; Gerl L; Dettmer N; Glomme S; Hess CF
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1348-57. PubMed ID: 12654447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous delivery of IFN-beta promotes sustained maturation of intratumoral vasculature.
    Dickson PV; Hamner JB; Streck CJ; Ng CY; McCarville MB; Calabrese C; Gilbertson RJ; Stewart CF; Wilson CM; Gaber MW; Pfeffer LM; Skapek SX; Nathwani AC; Davidoff AM
    Mol Cancer Res; 2007 Jun; 5(6):531-42. PubMed ID: 17579115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxia.
    Zhu H; Yang X; Ding Y; Liu J; Lu J; Zhan L; Qin Q; Zhang H; Chen X; Yang Y; Yang Y; Liu Z; Yang M; Zhou X; Cheng H; Sun X
    Sci Rep; 2015 Sep; 5():14503. PubMed ID: 26412785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-dependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs.
    Shinohara ET; Geng L; Tan J; Chen H; Shir Y; Edwards E; Halbrook J; Kesicki EA; Kashishian A; Hallahan DE
    Cancer Res; 2005 Jun; 65(12):4987-92. PubMed ID: 15958537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enhancement of tumor radioresponse by combined treatment with cepharanthine is accompanied by the inhibition of DNA damage repair and the induction of apoptosis in oral squamous cell carcinoma.
    Harada T; Harada K; Ueyama Y
    Int J Oncol; 2012 Aug; 41(2):565-72. PubMed ID: 22664937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined radiation sensitizing and anti-angiogenic effects of ionizing radiation and the protease inhibitor ritonavir in a head and neck carcinoma model.
    Maggiorella L; Wen B; Frascogna V; Opolon P; Bourhis J; Deutsch E
    Anticancer Res; 2005; 25(6B):4357-62. PubMed ID: 16309240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the microenvironment for radiosensitization by patupilone.
    Bley CR; Jochum W; Orlowski K; Furmanova P; Vuong V; McSheehy PM; Pruschy M
    Clin Cancer Res; 2009 Feb; 15(4):1335-42. PubMed ID: 19228735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.